Rentschler Biopharma is a specialist biologics CDMO focused on process development, clinical manufacturing, commercial manufacturing, analytical development, and regulatory support for biopharmaceutical products. The company has a long history in biologics manufacturing and serves sponsors across Europe, North America, and other markets.

Regenxbio is an established gene therapy company focused on adeno-associated virus vectors and genetic medicine. The company has built its platform around AAV delivery technology and has programs in rare disease, ophthalmology, neurodegenerative disease, and other inherited disorders.

Regeneron Pharmaceuticals is one of the strongest research-driven biotechnology firms globally, known for its antibody discovery capabilities, internal science culture, and successful commercial products across ophthalmology, immunology, oncology, and rare diseases.

Recordati Rare Diseases is a focused orphan drug platform within Recordati, serving patients with rare endocrine, metabolic, oncologic, and inherited disorders. The business has built a portfolio of specialty medicines for diseases requiring specialist diagnosis and long-term management.

Recipharm is a European CDMO with a broad pharmaceutical manufacturing platform spanning sterile manufacturing, oral solid dose, inhalation products, analytical services, development, and commercial supply. The company serves pharmaceutical and biotechnology sponsors across multiple dosage forms and therapeutic categories.

PTC Therapeutics is an established rare disease company focused on neurological, neuromuscular, metabolic, and genetically defined disorders. The company has developed therapies for rare diseases such as Duchenne muscular dystrophy and aromatic L-amino acid decarboxylase deficiency, among other programs.

PSI CRO is a privately held full-service CRO with a strong reputation in clinical trial execution, particularly for sponsors seeking operational focus, therapeutic expertise, and global study management. The company supports Phase II–III and related clinical development programs across multiple therapeutic areas.

ProPharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Premier Research is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Diagnostic Imaging Associates is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Diagnostic Imaging Providers 1 ranking category Overview

Diagnexia is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Pathology & Laboratory Networks 1 ranking category Overview

DeepHealth is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III AI-Enabled Diagnostics Providers 1 ranking category Overview

Dasa Diagnósticos is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Pathology & Laboratory Networks 1 ranking category Overview

Cue Health is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Mobile & At-Home Diagnostics Providers 1 ranking category Overview

Craft Body Scan is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Preventive Health Screening Providers 1 ranking category Overview

CPL — Clinical Pathology Laboratories is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Pathology & Laboratory Networks 1 ranking category Overview

Congenica is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Genetic Testing & Genomics Providers 1 ranking category Overview

Color Health is a population health and genomics provider focused on making genetic testing more accessible and actionable across broader patient populations. The company began with hereditary cancer risk testing and has since expanded into population health implementation, clinical programs, and preventive care infrastructure.

Cobalt Health is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Diagnostic Imaging Providers 1 ranking category Overview

Cleerly is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III AI-Enabled Diagnostics Providers 1 ranking category Overview